Plasma Testosterone and Sexual Function in Men Receiving Buprenorphine Maintenance for Opioid Dependence
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
High-dose methadone is well known to cause testosterone deficiency and sexual dysfunction in opioid-dependent men. Buprenorphine is a new drug for the pharmacotherapy of opioid dependence. Its influence on the gonadal axis has not been investigated to date. We therefore assayed testosterone, free testosterone, estradiol, SHBG, LH, FSH, and prolactin in 17 men treated with buprenorphine. Thirty-seven men treated with high-dose methadone and 51 healthy blood donors served as controls. Sexual function and depression were assessed using a self-rating sexual function questionnaire and the Beck Depression Inventory. Patients treated with buprenorphine had a significantly higher testosterone level [5.1 +/- 1.2 ng/ml (17.7 +/- 4.2 nmol/liter) vs. 2.8 +/- 1.2 ng/ml (9.7 +/- 4.2 nmol/liter); P < 0.0001] and a significantly lower frequency of sexual dysfunction (P < 0.0001) compared with patients treated with methadone. The testosterone level of buprenorphine-treated patients did not differ from that of healthy controls. In conclusion, we demonstrated for the first time that buprenorphine, in contrast with high-dose methadone, seems not to suppress plasma testosterone in heroin-addicted men. To this effect, buprenorphine was less frequently related to sexual side effects. Buprenorphine might therefore be favored in the treatment of opioid dependence to prevent patients from the clinical consequences of methadone-induced hypogonadism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Buprenorphine, a partial opioid receptor agonist, is associated with milder effects on the hypothalamic-pituitary-gonadal system (91,92).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [91]
In the citing paper
“In patients on methadone or buprenorphine maintenance treatment, PRL has been found to be reduced, similar, or higher when compared with controls (91,150,151).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [91]
Citations
Cites
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
A Controlled Trial of Buprenorphine Treatment for Opioid Dependence
Johnson, R. E. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480200058024 · Cited by 572
Function of the Male Sex Organs in Heroin and Methadone Users
Cicero, T. J., Bell, R. D., Wiest, W. G., Allison, J. H., Polakoski, K., & Robins, E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197504242921703 · Cited by 246
Buprenorphine: how to use it right
JOHNSON, R. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00060-7 · Cited by 241
The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic
WALSH, S. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00056-5 · Cited by 219
Plasma testosterone levels in heroin addiction and during methadone maintenance.
Mendelson, J. H., Mendelson, J. E., & Patch, V. D. (1975) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30047-9 · Cited by 148
Decreased serum testosterone concentration in male heroin and methadone addicts
Azizi, F., Vagenakis, A. G., Longcope, C., Ingbar, S. H., & Braverman, L. E. (1973) · Steroids · doi:10.1016/0039-128x(73)90002-0 · Cited by 130
Clinical efficacy of buprenorphine: comparisons to methadone and placebo
LING, W. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00059-0 · Cited by 121
Opioid-induced suppression of rat testicular function.
Adams, M. L., Sewing, B., Forman, J. B., Meyer, E. R., & Cicero, T. J. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38343-6 · Cited by 87
Cited by
Items 201–258 of 258
Playing It Safe: A Video Game Probing the Relationship Between Addiction, Gender, and Avoidance
Shi, Z., Wang, A.-L., & Langleben, D. D. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16com10752 · Cited by 1
Present and Future Pharmacological Treatments for Opioid Addiction
Blanco-Gandía, M. C., Montagud‐Romero, S., & Rodríguez‐Arias, M. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.82443 · Cited by 1
“Methadone can also inhibit gonadotropin-releasing hormones, lowering testosterone levels [40, 41].”
BackgroundAL-Shemary, N. N. A. (2023) · Journal of Wasit for Science and Medicine · doi:10.31185/jwsm.454 · Cited by 1
Arvinth, A., Umamaheswari, S., Suganya, E., & Sakthibalan, M. (2025) · Journal of Current Research in Scientific Medicine · doi:10.4103/jcrsm.jcrsm_12_25 · Cited by 1
Tramadol induces hormonal imbalance, histopathology, and altered ovarian gene expression in mice
Azimi, H., Abdollahifar, M., Zarrinpour, V., & Aliaghaei, A. (2025) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2024.07773 · Cited by 1
“Bliesener et al. [31] explained that the impact of tramadol on GnRH is mediated by elevated prolactin levels, which contribute to the decrease in GnRH.”
Banwell, C. L., Dance, P., Olsen, A., & Dixon, J. (2009) · TSpace (University of Toronto) · Cited by 1
SEX AND GENDER DIFFERENCES IN THE MANAGEMENT AND TREATMENT OF OPIOID ADDICTION
Bawor, M. (2015) · MacSphere (McMaster University) · doi:10.71548/19054 · Cited by 1
Bishop, B. (2016) · Massey Research Online (Massey University) · Cited by 1
Sexuelle Funktionsstörungen bei Substitutionstherapie mit Methadon und Levomethadon
Häbel, T. (2016) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-14506 · Cited by 1
Hull, E. M., & Dominguez, J. M. (2012) · Wiley eBooks · doi:10.1002/9781118133880.hop203012 · Cited by 5
Maintenance Therapy and Sexual Behavior
Giacomuzzi, S. M., Garber, K., Farneti, A., & Riemer, Y. (2011) · InTech eBooks · doi:10.5772/27185
“One previous study found that buprenorphine has fewer negative effects on male sexual performance than methadone (Bliesener et al., 2005).”
BackgroundResultCommentary on Greyet al. (2011): Does methadone maintenance therapy adversely affect bone mass?
Nakchbandi, I. A. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03278.x
For information on reprint requests of more than 101 and commercial reprints contact
Barbour, L. A., Cobin, R. H., DeGroot, L. J., Glinoer, D., Mandel, S. J., & Edwards, H. A. (2008)
The Impact of Pain Medications on the Endocrine System
Gevirtz, C. (2005) · Topics in Pain Management · doi:10.1097/00587875-200511000-00001
Buprenorfinepleisters: Meer van hetzelfde of een aanwinst voor pijntherapie?
Zylicz, B. (2008) · Pallium · doi:10.1007/bf03080294
Montori, V. M., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., & Ronald, S. H. (2010)
Popescu, A., Mitra, R., & Ballantyne, J. C. (2006) · Journal of Opioid Management · doi:10.5055/jom.2006.0007
Prescription Medications that Affect Sexual Function
Herberts, M. B., & McVary, K. T. (2016) · Springer eBooks · doi:10.1007/978-3-319-31587-4_11
Roantree, E., & Żylicz, Z. (2009) · Palliative Medicine in Practice
Hypogonadism in an opioid dependent man
Nkire, N., Doran, M., & O'Connor, J. J. (2011) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700012209
Bhoir, K. K., Suryawanshi, S., & Pandey, A. (2016) · JOURNAL OF EXPERIMENTAL ZOOLOGY INDIA
El-Zawakry, Z., Ismail, M., & El-Fotoh, M. F. A. (2015) · Ain Shams Journal of Forensic Medicine and Clinical Toxicology · doi:10.21608/ajfm.2015.18583
Kharat, A. A. (2018) · UNM’s Digital Repository (University of New Mexico)
Davoodian, N., Khetvan-Hafshejani, R., Kadivar, A., Mousavi, M. M., Aali, E., Gheami, A., Moghadam, B. B., & Shirian, S. (2019) · The Neuroscience Journal of Shefaye Khatam · doi:10.29252/shefa.7.3.74
Masoud, R. E. (2016) · Suez Canal University Medical Journal · doi:10.21608/scumj.2016.116293
“These drugs inhibit the secretion of luteinizing hormone (LH) by acting either in the hypothalamus or directly in the pituitary gland, which leads to reduced serum testosterone levels(20).”
BackgroundThe Effect of Methadone on Sexual Function in Men Dependent on Opiates
Jirdehi, R. (2016) · Community Medicine & Public Health Care · doi:10.24966/cmph-1978/100013
Implication of Prolonged Administration of Tramadol on Reproductive Performance of Male Wistar Rats
Oladejo, A. O., Ajala, O. O., Bakre, A., Oloye, A. A., & Ajani, O. S. (2020) · Scholars Journal of Agriculture and Veterinary Sciences · doi:10.36347/sjavs.2020.v07i09.001
“Various studies have demonstrated opioid effects on a variety of hormones including but not limited to testosterone (both total and free) [8, 9], luteinizing hormone (LH) [8, 10], gonadotrophin releasing hormone (GnRH) [11, 12] and cortisol [13].”
BackgroundFerguson, S., & Teitelbaum, A. (2021) · Psychiatry update · doi:10.1007/978-3-030-86430-9_7
Effect of Tramadol on Hormones and Lipid Peroxidation of male Rabbits
Eman, G. A. A., Omar, O. E. I., & Khaled, F. A. (2021) · Journal of Chemistry and Applications · doi:10.36811/jca.2021.110036
Buprenorfinepleisters: Meer van hetzelfde of een aanwinst voor pijntherapie?
Zylicz, B. (2009) · Pallium · doi:10.1007/bf03087780
Cheatle, M. D., & Gallagher, R. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-95369-4_25
(2022) · Elsevier eBooks · doi:10.1016/b978-3-437-23673-0.00006-9
(2015) · Elsevier eBooks · doi:10.1016/b978-3-437-23671-6.00006-7
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000224813.85060.ab
Masoud, R. E. (2017) · Suez Canal University Medical Journal · doi:10.21608/scumj.2017.46989
(2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23672-3.00006-8
Cancer Pain Management, Opioid Side Effects, Endocrine Changes, and Sexual Dysfunction
Portenoy, R. K., & Ahmed, E. (2013) · Springer eBooks · doi:10.1007/978-3-642-28753-4_534
Complications of Opiate Therapy
Sader, E., Calvino, S., & Gharibo, C. G. (2022) · Wiley eBooks · doi:10.1002/9781119757306.ch6
saleh, A. A., & El-Sayed, A. (2022) · Egyptian Society of Clinical Toxicology Journal · doi:10.21608/esctj.2022.163261.1014
Physical Health and Fatherhood
Parent, M. C., & Woznicki, N. W. (2022) · Springer eBooks · doi:10.1007/978-3-031-14498-1_12
Effect of daily tramadol administration on sperm indices and morphology of testes in rabbits
Emokpae, M. A., Femi-Idris, O., & Onuyoh-Adaitire, B. (2022) · Manipal Journal of Nursing and Health Sciences · doi:10.55889/2582-7979.1262
Kaur, G., Sidana, A. K., & Singh, S. (2024) · Journal of Psychosexual Health · doi:10.1177/26318318241255785
Substance Abuse - New Compounds and New Problems
Zaragoza, J. N. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1005953
Medical Care for Patients with Substance Use Disorders
Buresh, M., & Rastegar, D. A. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197796207.003.0014
de Tamaulipas, U. A., & Ávila, J. P. (2025) · doi:10.29059/luat.433
Does Morphine Abuse Harm Male Reproductive System?
Görmüş, Z. I. S., & Koca, R. Ö. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1010051
Effect of Long-Term Opioid Therapy on Sexual Dysfunction in Pain Patients
Streett, M., Chandler, M., Luciani, L. L., Cetto, A. V., Kathol, J., & Painter, J. T. (2025) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2025.2599362
“These results align with previous research conducted in OUD populations and highlight buprenorphine’s possible advantageous pharmacologic properties over other full-agonist opioids.”
InfluentialOpioids and sexual health: A narrative review
Shekhar, A., Phillip, S., & Basu, A. (2021) · Indian Journal of Health, Sexuality and Culture · doi:10.5281/zenodo.5151805
Habibi, A. (2021) · Research Information System of Ardabil University of Medical Sciences (Ardabil University of Medical Sciences)
Breuer, A. (2008) · bonndoc (University of Bonn)
Moradi, F. (2020) · Research Information System of Ardabil University of Medical Sciences (Ardabil University of Medical Sciences)
Geschlechtsunterschiede bei der psychopharmakologischen Behandlung psychiatrischer Erkrankungen
Bäwert, A., Winklbaur, B., Metz, V., & Fischer, G. (2009) · Journal für Kardiologie (Krause & Pachernegg GmbH)
The association of methadone use with physical function and frailty among persons who inject drugs
Ditzenberger, G. L., Hsu, H., Rudolph, J. E., Jiang, Y., Erlandson, K. M., Piggott, D. A., Mehta, S., Walston, J. D., Kirk, G. D., Brown, T., et al. (2025) · Addiction · doi:10.1111/add.70306
“Our findings suggest that even substance use bupre-norphine, which has a more favorable effect on the gonadal axis, may provide an alternative to reduce long-term impact [31].”
Khalilzadeh, M., Dorooshi, G., Samsamshariat, S., Feizi, A., Bamarinejad, A., Nouri, R., Meamar, R., & Eizadi‐Mood, N. (2026) · Current Addiction Reports · doi:10.1007/s40429-026-00757-9
“The prevalence of SD in patients receiving opioid agonist therapy remains clinically significant, with studies reporting that up to 83% of men undergoing BMT experience at least one domain of sexual dysfunction [ 30 , 34 ].”
InfluentialSexual Dysfunctions Special Issues
Goshtasebi, A. (2011)
Shveta, D., Kumar, Agarwal, & Agarwal (2026) · Student s Journal of Health Research Africa · doi:10.51168/pbk9g586
Metadata
- Authors
- Bliesener, N., Albrecht, S., Schwager, A., Weckbecker, K., Lichtermann, D., & Klingmüller, D.
- Affiliations
- University of Bonn (DE)
- ORCID
- Weckbecker, Klaus
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-01
- Volume
- 90
- Issue
- 1
- Pages
- 203-206
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2164669880
- Semantic Scholar
- 6b922b7d804a6488ee6c5032a29f420570446a72
- Cited by
- 236
- References
- 14
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 6 · 2023: 5 · 2022: 15 · 2021: 13 · 2020: 9 · 2019: 16 · 2018: 15 · 2017: 11 · 2016: 15 · 2015: 8 · 2014: 14 · 2013: 16 · 2012: 16
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- buprenorphine, methadone, opioid use disorder, testosterone, sexual dysfunction, hypogonadism, heroin addiction, gonadal axis, depression, gonadotropins, prolactin, estradiol, sex hormone-binding globulin
- MeSH terms
- Adult, Buprenorphine, Estradiol, Humans, Male, Methadone, Opioid-Related Disorders, Sexual Behavior, Sex Hormone-Binding Globulin, Testosterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.